News

Fintel reports that on April 21, 2023, Cantor Fitzgerald initiated coverage of Progyny (NASDAQ:PGNY) with a Overweight recommendation.

Analyst Price Forecast Suggests 30.15% Upside

As of April 6, 2023, the average one-year price target for Progyny is $45.08. The forecasts range from a low of $34.34 to a high of $50.40. The average price target represents an increase of 30.15% from its latest reported closing price of $34.64.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Progyny is $1,058MM, an increase of 34.45%. The projected annual non-GAAP EPS is $0.39.

What is the Fund Sentiment?

There are 611 funds or institutions reporting positions in Progyny. This is a decrease of 11 owner(s) or 1.77% in the last quarter. Average portfolio weight of all funds dedicated to PGNY is 0.38%, an increase of 7.80%. Total shares owned by institutions increased in the last three months by 10.57% to 114,013K shares.

The put/call ratio of PGNY is 0.71, indicating a bullish outlook.

What are Other Shareholders Doing?

Tpg Gp A holds 9,250K shares representing 9.81% ownership of the company. In it's prior filing, the firm reported owning 10,000K shares, representing a decrease of 8.11%. The firm decreased its portfolio allocation in PGNY by 6.83% over the last quarter.

KPCB XIII Associates holds 6,474K shares representing 6.86% ownership of the company. In it's prior filing, the firm reported owning 7,406K shares, representing a decrease of 14.41%. The firm decreased its portfolio allocation in PGNY by 99.88% over the last quarter.

Macquarie Group holds 4,989K shares representing 5.29% ownership of the company. In it's prior filing, the firm reported owning 6,615K shares, representing a decrease of 32.61%. The firm decreased its portfolio allocation in PGNY by 78.02% over the last quarter.

Clearbridge Investments holds 3,989K shares representing 4.23% ownership of the company. In it's prior filing, the firm reported owning 3,818K shares, representing an increase of 4.27%. The firm decreased its portfolio allocation in PGNY by 14.00% over the last quarter.

Thrivent Financial For Lutherans holds 2,593K shares representing 2.75% ownership of the company. In it's prior filing, the firm reported owning 2,507K shares, representing an increase of 3.31%. The firm decreased its portfolio allocation in PGNY by 99.92% over the last quarter.

Progyny Background Information
(This description is provided by the company.)

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.

See all Progyny regulatory filings.

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.